Circuit Courts, State Laws to Test Drug Discount Program in 2024
Healthcare attorney Susan Banks was quoted in a Bloomberg Law article about the ongoing debates surrounding the 340B Drug Pricing Program. The article discusses how pending court cases and new administrative rules could significantly change how the 340B program operates and who benefits from the discounted drug prices. Ms. Banks highlighted that the core issues of the purpose and application of 340B savings remain hotly contested and are likely to be discussed throughout the year. She emphasized the significance of these discussions, stating they will play a crucial role in shaping the program's operations and the beneficiaries of its savings.
"There remains a really open, very live, vigorous debate on what is the purpose of these 340B savings and how hospitals deploy their resources when they save money via 340B purchases," Ms. Banks said. "Those issues are still very live, and I would expect to see all debated in the coming year."